
David Kim
Managing Director
David has deep experience in healthcare and investment, having started as a clinician and moved on to roles like COO at a growth-stage company. He worked as principal at MPM Capital and a partner at Pinnacle Ventures and serves as a board member for several biotech companies.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$1M - $3M
$3M - $10M
Focus areas
Health
Deeptech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.